Mylan: Top and Latest News, Videos and Photos about Mylan

Showing 122 results for

Biocon’s prospects look good, but Street eyes better execution

1 min read . Updated: 15 Apr 2021

Biocon’s Kiran Mazumdar-Shaw says the synergistic partnership will enable us to scale up our capabilities for an end-to-end play in the global biosimilars space. Photo: Hemant Mishra/Mint

Investor sentiment for Biocon softens as US FDA defers drug approval

1 min read . Updated: 28 Dec 2020

Biocon’s Kiran Mazumdar-Shaw says the synergistic partnership will enable us to scale up our capabilities for an end-to-end play in the global biosimilars space. Photo: Hemant Mishra/Mint

FDA informs Biocon, Mylan of deferred action on Avastin biosimilar BLA

1 min read . Updated: 25 Dec 2020

The Taloja plant, officially called Unit 11, is one of two API facilities in India

Viatris plant on sale amid restructuring

1 min read . Updated: 14 Dec 2020

Gland Pharma may get listed before Diwali.mint (MINT_PRINT)

Gland Pharma plans entry into China and Africa

3 min read . Updated: 05 Nov 2020

The US FDA had inspected the plant at Pashamylaram in Telangana from February 24 to 28 this year

Mylan receives US FDA warning for lack of quality control at Telangana unit

1 min read . Updated: 01 Sep 2020

Insulin glargine is approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. Photo: AFP

Biocon Biologics, partner Mylan launch insulin glargine in US

2 min read . Updated: 31 Aug 2020

More than half of 123 companies permitted to import medicines from other nations are Indian companies

Covid-19: Three Indian companies start supply of life-saving Remdesivir to Nepal

1 min read . Updated: 21 Aug 2020

Jubilant Generics Ltd, an arm of the Noida-based pharmaceutical firm, will make the drug available to over 1,000 hospitals providing covid-19 treatment in India through its distribution network and will also provide a 24-hour helpline to enhance access to the drug during the pandemic.

Jubilant Life arm launches covid drug remdesivir as JUBI-R at ₹4,700/vial

1 min read . Updated: 03 Aug 2020

Not-for-profit TB Alliance granted a non-exclusive license to Mylan to manufacture and sell pretomanid in April last year

Mylan gets Indian regulatory approval for tuberculosis drug

1 min read . Updated: 22 Jul 2020

My Reads Redeem a Gift Card Logout